LitAlert ~~ GeneLit.com

    • Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? A systematic review and meta-analysis.
    • Nara M, Ishihara S, Kitano A, Tamura N, Aruga T, Kobayashi D, Nakamura S, Yamauchi H.
    • Breast Cancer. 2022 Feb 25. doi: 10.1007/s12282-022-01343-3. Epub ahead of print.
    • Meta-Analysis
    • PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas.
    • Jones N, Gros A, Velasco V, Dapremont V, Brouste V, Gastaldello B, Debled M, de Lara CT, Bonnet F, Barouk-Simonet E, Bubien V, Venat L, MacGrogan G, Longy M, Sevenet N.
    • Cancer Genet. 2022 Feb 24. doi: 10.1016/j.cancergen.2022.02.008. Epub ahead of print.
    • Guidelines for Management of Treatment-Emergent Adverse Events During Rucaparib Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer.
    • Labadie BW, Morris DS, Bryce AH, Given R, Zhang J, Abida W, Chowdhury S, Patnaik A.
    • Cancer Manag Res. 2022 Feb 17;14:673-686. doi: 10.2147/CMAR.S335962.
    • PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer.
    • Kraya AA, Maxwell KN, Eiva MA, Wubbenhorst B, Pluta J, Feldman M, Nayak A, Powell DJ Jr, Domchek SM, Vonderheide RH, Nathanson KL.
    • JCO Precis Oncol. 2022 Feb;6:e2100159. doi: 10.1200/PO.21.00159.
    • An Unexpected Tumor Reduction: Treatment with Olaparib Monotherapy in Heavily Pretreated BRCA2 Mutated Metastatic Pancreatic Cancer.
    • Prete AA, Procaccio L, Bergamo F, Rasola C, Nappo F, Zagonel V, Lonardi S.
    • Curr Oncol. 2022 Jan 27;29(2):544-550. doi: 10.3390/curroncol29020049.